Loading...
Loading...
Among the 9 tracked institutional investors we monitor, MIRM (MIRUM PHARMACEUTICALS INC) is held with a combined value of $1.18B across 13,166,049 shares. The largest holder is BlackRock, Inc. with a position worth $355.34M (0.01% of their portfolio). 2 funds opened new positions in the most recent quarter. 6 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$1.18B
Total Shares Held
13,166,049
Institutional Holders
9
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $355.34M | 0.01% | +5.5% |
| 2 | VANGUARD GROUP INC | $205.07M | 0.00% | New |
| 3 | FMR LLC | $181.56M | 0.01% | +204.0% |
| 4 | STATE STREET CORP | $179.61M | 0.01% | -9.3% |
| 5 | CITADEL ADVISORS LLC | $98.25M | 0.02% | +24.7% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $53.77M | 0.08% | +32.6% |
| 7 | BAKER BROS. ADVISORS LP | $41.20M | 0.24% | New |
| 8 | MILLENNIUM MANAGEMENT LLC | $34.05M | 0.01% | +50.9% |
| 9 | Point72 Asset Management, L.P. | $32.66M | 0.04% | +70.8% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of MIRM with a position worth $355.34M, representing 0.01% of their portfolio. In total, 9 institutional investors hold MIRM with a combined value of $1.18B.
In the most recent quarter, 2 funds opened a new position in MIRM. Additionally, 6 increased their holdings and 1 reduced their positions.
Institutional investors hold $1.18B worth of MIRM stock across 9 positions. The largest institutional holder is BlackRock, Inc. with $355.34M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MIRM, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MIRM positions.